Skip to main content

Advertisement

Table 3 Mapping. Number of probe sets able to be mapped across datasets during independent validations.

From: Predicting prognosis using molecular profiling in estrogen receptor-positive breast cancer treated with tamoxifen

Cluster no. Total probe sets present in classifier Mapped
   GUYT2 dataset Ma dataset Reid dataset Jansen dataset
79 7 7 3 1 2
148 45 45 23 23 15
112 14 14 5 4 9
120 38 38 18 15 16
375 8 8 4 3 3
201 17 17 5 8 6
521 19 19 10 8 5
784 7 7 1 1 1
859 7 7 4 2 2
360 14 14 4 2 0
231 26 26 8 4 9
110 30 30 13 3 10
337 7 7 4 1 1
Total n (%) 239 (100%) 239 (100%) 102 (42.6%) 75 (31.4%) 73 (30.5%)